What are the limitations of the SYNTAX Score II?

While the SYNTAX Score II is highly validated, it should not replace clinical judgment. OpiCalc provides the latest evidence-based limitations for the SYNTAX Score II to ensure safe bedside use and optimal diagnostic accuracy.

How does the SYNTAX Score II compare to other Cardiovascular scores?

The SYNTAX Score II is a gold-standard diagnostic tool. OpiCalc provides side-by-side clinical guidance to help clinicians choose the most specific evidence-based tool for their patient's presentation.

Is the SYNTAX Score II free to use?

Yes. OpiCalc provides the SYNTAX Score II completely ad-free and optimized for mobile bedside use, ensuring you can calculate medical risk swiftly and without distraction.

EVIDENCE SYNTHESIS

Clinical Reference Hub

Curated insights • How it Works • Practical Pearls • Evidence Base

CLINICAL INSIGHT

When to Use

Patients with complex multi-vessel coronary artery disease (CAD) or left main disease being evaluated for revascularization.
To assist the "Heart Team" in deciding between Percutaneous Coronary Intervention (PCI) and Coronary Artery Bypass Grafting (CABG).
To predict 4-year all-cause mortality for both interventional strategies.

CLINICAL INSIGHT

How it Works

Beyond Anatomy

The original SYNTAX score is purely anatomical and often favors CABG in complex disease. However, for many patients (e.g., elderly, those with COPD), the surgical risk outweighs the anatomical benefit. SYNTAX Score II integrates 8 predictors to provide a more personalized risk assessment.

Model Predictors

Anatomical SYNTAX Score: Base anatomical complexity.
Age: Older age favors PCI (reduced surgical tolerance).
Creatinine Clearance (CrCl): Markers of renal fragility.
Left Ventricular Ejection Fraction (LVEF): Lower EF increases surgical risk.
Unprotected Left Main Disease: Clinical status of LMT.
Peripheral Vascular Disease (PVD): Associated with poor surgical/interventional outcomes.
COPD: Strong predictor of high surgical morbidity.
Female Sex: Associated with smaller vessels and different CABG/PCI outcomes.

CLINICAL INSIGHT

Practical Pearls

PCI vs. CABG: The Equipoise Zone

The algorithm identifies a "Treatment Equipoise" zone where predicted 4-year mortality is similar between PCI and CABG. In these cases, patient preference and local procedural expertise should drive the decision.

ESC/EACTS Guidelines

The 2018 ESC Guidelines on Myocardial Revascularization endorse the use of SYNTAX Score II (Class IIa) for complex CAD decision-making.

CLINICAL INSIGHT

Evidence Base

Development & Validation

Anatomical and clinical SYNTAX score II to individualize the decision-making between percutaneous and surgical revascularization.

Farooq V, van Klaveren D, Steyerberg EW, et al.Lancet.2013

CLINICAL INSIGHT

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Use

How it Works

Beyond Anatomy

Model Predictors

Practical Pearls

PCI vs. CABG: The Equipoise Zone

ESC/EACTS Guidelines

Evidence Base

Development & Validation

Next Steps

Complementary Calculators

SYNTAX Score II

Anatomical & Age

Clinical Comorbidities

Clinical Reference Hub

When to Use

When to Use

How it Works

Beyond Anatomy

Model Predictors

Practical Pearls

PCI vs. CABG: The Equipoise Zone

ESC/EACTS Guidelines

Evidence Base

Development & Validation

Next Steps

Complementary Calculators

Clinical Evidence and Methodology

Clinical Reference Hub

When to Use

When to Use

How it Works

Beyond Anatomy

Model Predictors

Practical Pearls

PCI vs. CABG: The Equipoise Zone

ESC/EACTS Guidelines

Evidence Base

Development & Validation

Next Steps

Complementary Calculators

SYNTAX Score II

Anatomical & Age

Clinical Comorbidities

Clinical Reference Hub

When to Use

When to Use

How it Works

Beyond Anatomy

Model Predictors

Practical Pearls

PCI vs. CABG: The Equipoise Zone

ESC/EACTS Guidelines

Evidence Base

Development & Validation

Next Steps

Complementary Calculators